Effect of cross-linking on physicochemical properties of chitosan mucoadhesive microspheres: A factorial approach

R. Kotadiya, V. Patel, H. Patel, H. Koradiya

Abstract


The objective of the present study was to develop chitosan-based mucoadhesive microspheres of Clarithromycin, to provide a prolonged
contact time for drug delivery of antibiotics, to treat stomach ulcers. Chitosan mucoadhesive microspheres with small particle size and good sphericity were prepared by an emulsification technique using glutaraldehyde as a cross linking agent. Glutaraldehyde, the aldehyde most frequently employed as a chemical cross linker agent for proteins, was also used as a control. The prepared microspheres were optimized by 32 factorial design, using the concentration of the cross linking agent (X1) and time of cross linking (X2) with respect to their morphological aspects, percentage entrapment, in-vitro drug release and percentage mucoadhesion. Microspheres
were discrete, spherical and free flowing. The microspheres exhibited a good mucoadhesive property in the in vitro wash-off test and also showed a high percentage of drug entrapment efficiency. The best batch exhibited a high drug entrapment efficiency of 45% and percentage mucoadhesion after 5 hours was 15%. The drug release from microspheres was characterized by the initial burst effect followed by sustained release for more than 12 hours. It was concluded that drug entrapment efficiency was increased with an increase in glutaraldehyde concentration and an increase in cross linking time. As the glutaraldehyde concentration and cross linking time increased, the percentage of mucoadhesion decreased. Thus chitosan microspheres appeared to be, technically, promising mucoadhesive drug delivery systems for delivering Clarithromycin, to treat stomach ulcers.
Key words: Chitosan, clarithromycin, cross linking, factorial design, glutaraldehyde, mucoadhesive microspheres

Full Text:

PDF

References


Chun M, Sah H, Choi H. Preparation of mucoadhesive

microspheres containing antimicrobial agents for eradication of

Helicobactor pylori. Int J Pharm 2005;297:172-9.

Kanamaru T, Nakano Y, Toyoda Y, Miyagawa KI, Tada M, Kaisho T,

et al. In vitro and in vivo antibacterial activities of TAK-o83, an agent

for treatment of Helicobactor pylori infection. Antimicrob Agents

Chemother 2001;45:2455-9.

Higo S, Ori K, Takeuchi H, Yamamoto H, Hino T, Kawashima Y.

A novel evaluation method of gastric mucoadhesive property

in-vitro and the mucoadhesive mechanism of tetracyclinesucralfate

acidic complex for eradication of Helicobactor pylori.

Pharm Res 2003;21:413-9.

Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M,

Ogawa Y. Mucoadhesive microspheres containing amoxicillin

for clearance of Helicobactor pylori. Antimicrob Agents Chemother

;42:2492-4.

Patel JK, Bodar MS, Patel AA. Formulation and optimization of

mucoadhesive microspheres of metoclopramide. Indian J Pharma

Sci 2004;66:300-5.

Woodley J. Bioadhesion: New possibilities for drug administration?

Clin Pharmacokinet 2001;40:77-84.

Singla AK, Sharma ML, Dhawan S. Nifedipine loaded chitosan

microspheres: Internal structure characterization. Biotech

Histochem 2001;76:165-71.

Dini E, Alexandridou S, Kiparissides C. Synthesis and

characterization of cross-linked microspheres for drug delivery

application. J Microencapsul 2003;20:375-85.

Thanoo B, Sunny MC, Jayakrishnan A. Cross linked chitosan

microspheres: Preparation and evaluation as a matrix for the

controlled release of pharmaceuticals. J Pharm Pharmacol

;44:283-6.

Orienti I, Aiedeh K, Gianasi E, Bertasi V, Zecchi V. Indomethacin

loaded chitosan microspheres correlation between the erosion

process and the release kinetics. J Microencapsul 1996;13:463-72.

Vanessa L, Gonçalves, Mauro C, Laranjeira M, Valfredo T. Effect

of crosslinking agents on chitosan microspheres in controlled

release of diclofenac sodium, polímeros. Ciência e Tecnologia

;15:6-12.

Lehr CM, Bouwstra JA, Tukker JJ, Junginger HE. Intestinal transit

of bioadhesive microspheres in an in situ loop in the rat. J Control

Release 1990;13:51-62.

Chowdary KP, Rao YS. Design and in vitro and in vivo evaluation

of mucoadhesive microcapsules of glipizide for oral controlled

release: A technical note. AAPS PharmSciTech 2003;4:E39.

Ugwoke MI, Verbeke N, Kinget R. Microencapsulation of

Apomorphine HCl with gelatin. Int J Pharma 1997;148:23-32.

Reddy BP, Dorle AK, Krishna DR. Albumin microsphere: Effect

of process variables on size distribution and in-vitro release. Drug

Dev Indus Pharmacy 1990;16:1791-803.

Sahin S, Selek H, Ponchel G, Ercan MT, Sargon M, Hincal AA,

et al. Preparation, characterization and in vivo distribution of

terbutaline sulfate loaded albumin microspheres. J Control Release

;82:345-58.

Raymond G, Degennaro M, Mikeal R. Preparation of gelatin

phenytoin sodium microspheres: An in vitro and in vivo evaluation.

Drug Dev Indus Pharmacy 1990;16:1025-51.

Fan H, Dash AK. Effect of cross-linking on the in vitro release

kinetics of doxorubicin from gelatin implants. Int J Pharm

;213:103-16.

Chuo W, Tsai T, Hsu S, Cham T. Preparation and in vitro

evaluation of nifedipine loaded albumin microspheres crosslinked

by different glutaraldehyde concentrations. Int J Pharma

;144:241-5.




DOI: http://dx.doi.org/10.22377/ijgp.v3i1.57

Refbacks

  • There are currently no refbacks.